Journal of Rheumatology

Article	Citations
TREX1-Associated Familial Chilblain Lupus With Cerebral Aneurysms Treated With Janus Kinase Inhibition	105
Dr. Gottlieb et al reply	73
Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?	55
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort	53
A Move Toward Precision: Innovations in Measuring Spinal Mobility in Axial Spondyloarthritis	51
Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association With HLA-B27 in European and Ibero-American Populations	49
Canadian Rheumatology Association Annual Scientific Meeting; RBC Convention Centre (and Virtually); Winnipeg, Manitoba, Canada; February 28–March 2, 2024	42
Drs. Dai and Fan reply	33
Phase-Specific Healthcare Costs Associated With Giant Cell Arteritis in Ontario, Canada	32
Arthritis Mutilans in Jo1 Antisynthetase Syndrome	32
CONTEMPORARY KIDNEY OUTCOMES AMONG PATIENTS WITH LUPUS NEPHRITIS IN THE UNITED STATES	28
ANTI-Β2GLYCOPROTEIN I-INDUCED NEUTROPHIL EXTRACELLULAR TRAPS CAUSE ENDOTHELIAL ACTIVATION	28
The State of Patient-Reported Outcome Measures in Rheumatology	28
Advancing Psoriatic Disease Knowledge: Highlights From the GRAPPA 2024 Trainee Symposium	27
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting	26
Aneurysmal Disease in Patients With Takayasu Arteritis	26
50th Year of Publication: Revisiting the 1980s	26
How to Identify and Monitor Axial and Peripheral Psoriatic Arthritis by Magnetic Resonance Imaging	26
PRISTANE-INDUCED LUPUS MICE PRESENT INCREASED MEGAKARYOCYTE COUNTS ALONGSIDE OTHER HISTOPATHOLOGICAL FEATURES IN THE SPLENIC TISSUE	25
A Reciprocal Machine Learning Approach to Defining Physiologic Compensation of the Synovial Joint in Knee Osteoarthritis	24
Is There Relevance of a Positive Rheumatoid Factor in Systemic Sclerosis? A Systematic Review of the Literature	24
“Gallia est omnis divisa in partes tres”: Social Media Platforms as a New Educational Channel for Pediatric Rheumatology	23
The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis: Real-World Data	23
Transforming Psoriatic Disease Care Through Innovation and Real-World Data: GRAPPA 2025 Soapbox Highlights	22
DYSREGULATION OF THE EXPRESSION OF HUMAN RETROVIRUSES IN SYSTEMIC LUPUS ERYTHEMATOSUS	21

THE USE OF POLYSIMPTOMATIC DISTRESS SCALE IN A MULTICENTRIC COHORT OF SLE PATIENTS TO IDENTIFY PATIENTS WITH HIGH LEVELS TYPE 2 SYMPTOMS	21
OUTCOMES OF ADULTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUS: A SCOPING REVIEW	20
CD38 IS OVEREXPRESSED BY IMMUNE CELLS IN CUTANEOUS LUPUS SKIN	20
EFAVALEUKIN ALFA IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A BAYESIAN ADAPTIVE, PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED DOSE-RANGING STUDY	19
AN UNUSUAL CASE OF LYMPHOCYTIC ENTEROCOLITIS AND VASCULITIS AS THE INITIAL MANIFESTATION OF SLE	19
DELAYED ONSET OF MALE INFERTILITY AFTER TREATMENT WITH HIGH DOSE OF CYCLOPHOSPHAMIDE FOR LUPUS NEPHRITIS	19
EFFECT OF CENERIMOD, AN S1P1 MODULATOR, ON FATIGUE IN SLE: RESULTS FROM THE PHASE 2 CARE STUDY	19
Beyond Pain Intensity: The Relationship Between Pain Catastrophizing and Quality of Life in Psoriatic Arthritis	18
Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A	18
THE IMPORTANCE OF TRANS-ESOPHAGEAL ECHOCARDIOGRAPHY IN DIAGNOSING LIBMAN-SACKS ENDOCARDITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT	18
Description of Immune Checkpoint Inhibitor Associated Sicca-Like Syndrome from the Canadian Research Group of Rheumatology in Immuno-Oncology Database: A Case Series	17
Response to Treatment With Tofacitinib in 11 Patients With Refractory Granulomatosis With Polyangiitis	17
Challenges of Assessment of SpondyloArthritis international Society Criteria in Real-World Colombian Patients With Spondyloarthritis: A Cross-Sectional Study	17
Ultrasound in the Management of Patients With Psoriatic Arthritis: Systematic Literature Review and Novel Algorithms for Pragmatic Use	16
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study	16
Changes in Modern Care for Juvenile Idiopathic Arthritis: How Much Does This Affect Health-Related Quality of Life?	15
Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study	15
Modifiable Lifestyle Factors, Genetic Susceptibility, and Incident Radiographic Axial Spondyloarthritis	14
Factors Associated With an Electronic Health Record–Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease	14
HLA Class I Alleles as a Predictor of Retention to Treatment with Il-17 Antagonists in a Cohort of Patients with Psoriatic Arthritis in Newfoundland	14
Inflammation as a Treatment Target in Hand Osteoarthritis: A Review of Previous Studies and Future Perspectives	14
High Cardiovascular Burden from Glucocorticoid Exposure in Giant Cell Arteritis: A Retrospective Cohort Analysis	14
Peripheral Ulcerative Keratitis in VEXAS Syndrome	14
Fibrous Bands: An Alternate Diagnosis to Consider for Range of Motion Limitations in Suspected Juvenile Idiopathic Arthritis	14
Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist	14
Hacking Arthritis: Innovation and Adaptation in Daily Life	14
Do Mechanisms Matter? Comparing Early Clinical and Ultrasound Responses to Advanced Therapies in Biologic-Naïve Rheumatoid Arthritis	13
More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus	13
Long-Term Outcomes in Lung Transplant for Anti-Melanoma Differentiation-Associated Gene 5 Antibody Positive Interstitial Lung Disease: A Case Series	13
Drs. Chung and McMahan reply	13
SIMILARITY AND DIVERSITY IMMUNOLOGICAL ABERRATIONS IN STABLE BENIGN IMMUNITY AND TOWARD ANA-RELATED AUTOIMMUNE DISEASES IN ANA-POSITIVE AT-RISK POPULATIONS	13
ADMINISTRATION OF BELIMUMAB IN EARLY ACTIVE LUPUS PATIENTS HINDERS ACCRUAL OF EULAR/ACR CRITERIA WITHIN THE FIRST 12 MONTHS OF TREATMENT	13
Scrotal Calcinosis in Juvenile Systemic Sclerosis	13
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review	13
VARIATIONS IN TACROLIMUS WHOLE BLOOD CONCENTRATIONS DURING PREGNANCY AND ITS IMPLICATIONS FOR THERAPEUTIC DRUG MONITORING: A SYSTEMATIC REVIEW AND META-ANALYSIS	12
COVID-19 BOOSTER VACCINATION, EITHER MRNA OR PROTEIN SUBUNIT VACCINES, APPEARS SAFE IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS	12
The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study	12
SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF INDUCTION TREATMENTS FOR LUPUS NEPHRITIS	12
ASSOCIATION BETWEEN IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE OUTCOMES AND DISEASE ACTIVITY IN SLE: A REAL-WORLD COHORT STUDY	12
VALIDATION OF A SCORE FOR THE PREDICTION OF SERIOUS INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A LATIN AMERICAN LUPUS COHORT	12
FACTORS INFLUENCING SUBJECTIVE MENTAL ALTERATIONS: UNRAVELING THE LUPUS BRAIN FOG	12
INCREASE OF IL10 AND INFA2 ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS	12
GENETICS OF EGFR VARIABILITY AS A PROXY FOR LUPUS NEPHRITIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS	12
SERUM NEUROFILAMENT LIGHT TO DISTINGUISH AND MONITOR ACTIVITY IN A COHORT OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	11
CHARACTERISTICS OF NEUROLOGICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS AT A TERTIARY UNIVERSITY HOSPITAL	11
THE TYPE I IFN SIGNATURE BETWEEN PATIENTS WITH RA AND SLE.	11
Modulating the Gut-Joint Axis: The Impact of Anti-TNF Therapy on Gut Microbiota in Ankylosing Spondylitis - A Systematic Review	11
Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus	11
ASSESSMENT OF FATIGUE IN A MONOCENTRIC ITALIAN COHORT OF PATIENTS AFFECTED BY SLE AND OTHER RHEUMATIC DISEASES (RDS) THROUGH VALIDATED QUESTIONNAIRES	11
DRUG LEVELS AND ANTI-DRUG ANTIBODIES OVER 2 YEARS OF BELIMUMAB THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS	11

Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review	11
Negative Health Impacts of Navigating the Healthcare System for Musculoskeletal Conditions: Healthcare User Perspectives	11
The Efficacy of Leflunomide in the Treatment of Giant Cell Arteritis: A Systematic Review and Meta-Analysis	11
DOES SLEDAI-2K REFLECT THE INTERFERON-ALPHA GENE SIGNATURE IN SYSTEMIC LUPUS ERYTHEMATOSUS? PRELIMINARY RESULTS FROM A COHORT	11
ALL SUBCOMPONENTS OF THE CUTANEOUS LUPUS ERYTHEMATOSUS DISEASE AREA AND SEVERITY INDEX-ACTIVITY (CLASI-A) ARE RELEVANT TO IDENTIFY AND DETECT CHANGES IN SKIN ACTIVITY	11
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib	11
IMAGING INSIGHTS INTO JC VIRUS-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN NEUROPSYCHIATRIC LUPUS: A CASE REPORT	11
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment	10
Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients	10
Atlantoaxial Subluxation in Patients with Psoriatic Arthritis	10
The Uses and Advances in Imaging for Psoriatic Arthritis: A Scoping Review	10
Exploring Causal Relationships of Depression and Psoriatic Disease (Psoriatic Arthritis and Psoriasis) Through Mendelian Randomization	10
A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease	10
Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation	10
How Does Juvenile Idiopathic Arthritis Affect the Employment and Usual Activities of Adolescents? The UCAN CAN-DU and CURE International Prospective Study	10
Development of MOGAD in a Patient with Granulomatosis with Polyangiitis and Giant Cell Arteritis Overlap Syndrome	10
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study	10
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	10
Functional Connectivity and Structural Signatures of the Visual Cortical System in Fibromyalgia: A Magnetic Resonance Imaging Study	10
Text-Based Messaging to Support Rheumatoid Arthritis Care: An Analysis of the Frequency and Content of Text Messages	10
Current Barriers to Accessing Mental Healthcare Resources for Inflammatory Arthritis Patients and How to Improve Support	10
IMPACT OF BELIMUMAB ON EFFICACY, SAFETY AND IMMUNE PHENOTYPES IN REFRACTORY AND ACTIVE LUPUS NEPHRITIS IN REAL-WORLD LOOPS REGISTRY	9
A Systematic Review of Approaches to Manage Fatigue Among Children and Youth with Juvenile Idiopathic Arthritis	9
Risk of Retinopathy Associated with Long-Term Use of Hydroxychloroquine in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis	9
RANDOMIZED, PLACEBO-CONTROLLED PHASE II STUDY OF ENPATORAN, A SMALL MOLECULE TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM COHORT A	9
Do Monosodium Urate Crystals Reduce at Different Rates in Joints and Tendons During Urate-Lowering Therapy? A Dual-Energy Computed Tomography Study	9
Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases	9
The Ecological Relationship Between Food Access and Disease Activity in Canadian Children Newly Diagnosed With Juvenile Idiopathic Arthritis	9
Normalizing Uricemia in Psoriatic Arthritis: A Hypothetical Reduction of Atherosclerotic Plaque Burden	9
Epidemiological Characteristics of Patients With Juvenile Dermatomyositis in China: A Multicenter Study	9
Bimekizumab Clinical Efficacy Up to 2 Years Across Patients with Psoriatic Arthritis and Varying Baseline Joint Involvement: Results from a Post Hoc Analysis of 2 Pooled Phase 3 Studies	9
Dysregulation of the Cancer-Associated Glycan Polysialic Acid in Systemic Sclerosis: A Novel Biomarker and Anti-Fibrotic Target	9
Outcomes in Systemic Sclerosis–Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies	9
Dr. Joerns et al reply	9
Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis: Association With Immune Activation	9
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus	9
Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review	9
Idiopathic AA Renal Amyloidosis Treated with Tocilizumab — A Case Report	9
Exploring Facilitators and Barriers to Physiotherapists’ Delivery of a Falls Prevention Program with Brief Action Planning Counseling in Community-Dwelling Older Adults with a History of Falls	9
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculi	9
Epidemiological Characteristics of Psoriatic Disease in Peru From 2016 to 2023	9
Examination of HLA-DRB1*15–linked Candidate Antigens in Still Disease With and Without Lung Disease and Drug-Associated Immune Reactions	9
Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-Proven Patients	9
Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan	9
Number Needed to Screen for Axial Spondyloarthritis: Preliminary Results from the Fastrax Cohort	9
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study	8
Impaired Neutrophil Extracellular Trap (NET) Degradation in Rheumatoid Arthritis (RA) and Preclinical RA Is Mediated by Anti-NET Antibodies	8
A Clinical Audit of Vaccination in Patients Living with Inflammatory Arthritis and Receiving Specialty Medications	8
DOWNREGULATION OF YTHDF2 IN THE SPINAL DORSAL HORN CONTRIBUTES TO THE GENESIS OF CHRONIC PAIN INDUCED BY SYSTEMIC LUPUS ERYTHEMATOSUS	8
TYPE 2 LUPUS IS THE MAJOR PREDICTOR OF FATIGUE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CROSS-SECTIONAL STUDY OF 200 PATIENTS	8
CARDIAC LUPUS: A DISEASE NOT TO BE NEGLECTED.	8
Understanding the Resolution of Clinically Suspect Arthralgia: Moving Forward, but Challenges Remain	8
Knowledge About Human Papillomavirus Among Patients With Immune-Mediated Inflammatory Diseases	8
An Evaluation of Burnout Among US Rheumatology Fellows: A National Survey	8
Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry	8
Comparing Large Vessel Uptake of 68Ga-HA-DOTATATE to 18F-FDG Using PET/CT Imaging in Patients with Active Giant Cell Arteritis	8
EXPEDITING LUPUS CLASSIFICATION OF AT-RISK INDIVIDUALS USING NOVEL TECHNOLOGY: OUTCOMES OF A PILOT STUDY	8
VOLUME AND DYNAMIC BLOOD FLOW OF THE CHOROID PLEXUS IN NEUROINFLAMMATORY DISEASE	8
Elevated Serum Brain Injury Markers Correlate with Disease Features and Interferons in Children with Systemic Lupus Erythematosus	8
Sjögren Disease: Does an Accurate Diagnosis Matter?	8
The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases	8
Instagram as an Educational Platform for Familial Mediterranean Fever: A 33-Month Experience	8
Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2B/3 Trials	8
The Prognostic Potential of End-Stage Knee Osteoarthritis and Its Components to Predict Knee Replacement: Data From the Osteoarthritis Initiative	8
ADVANCES IN TARGETED THERAPIES AND IMMUNOMODULATORY STRATEGIES IN LUPUS	8
BRIDGING THE GAP: IDENTIFYING AND ADDRESSING BARRIERS TO CARE FOR PATIENTS WITH LUPUS AND LUPUS NEPHRITIS	8
The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis	8
High Frequency of Foot Insufficiency Fractures in Patients With Rheumatic Diseases Referred for Magnetic Resonance Imaging: What Is the Clinical Relevance?	7
GRAPPA 2024 Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees	7
GRAPPA 2024: Innovations in Education Workshop	7
Determinants of Cervical Cancer Screening Patterns Among Women With Systemic Lupus Erythematosus	7
More Than Skin Deep: Moving From a Skin-Based Phenotypic Model to Molecular Classification of Systemic Sclerosis	7
Comparative Outcomes in Pregnant Patients with Rheumatoid Arthritis Treated with and Without Tumor Necrosis Factor Inhibitors: A Systematic Review and Meta-Analysis	7
Granuloma Annulare as a Mimic for Rheumatoid Nodules: A Diagnostic Challenge	7
Novel Diagnostic and Prognostic Urinary Biomarker Model for Lupus Nephritis and Renal ANCA-Associated Vasculitis	7
Gaps in Care for Hydroxychloroquine-Related Retinopathy Screening in British Columbia: A Population-Based Cohort Study	7
Advances in Psoriatic Disease Research: Insights From GRAPPA Pilot Research Awardees	7
IMIQUIMOD-INDUCED ONSET OF DISEASE IN LUPUS-PRONE NZB/W F1 MICE	7
Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series	7
An Overview of Reviews to Inform Organization-Level Interventions to Address Burnout in Rheumatologists	7

Pursuing Gender Equity in Rheumatology: Thinking Beyond Gender Representation to Assess Gender Equality	7
Clinical and Histopathologic Characteristics and Outcomes of Patients With Psoriatic Arthritis Undergoing Arthroplasty	7
Brentuximab Vedotin in Severe Systemic Sclerosis: Data on Long-Term Follow-Up and Retreatment	7
Characterizing Systemic Lupus Erythematosus in Males: A Retrospective Chart Review Study from the Ottawa Hospital Lupus Clinic	7
Low Dose, High Impact: Acetylsalicylic Acid and Preterm Pre-Eclampsia Prevention in Rheumatic Disease	7
Association of the Apollo Wearable With Fatigue, Raynaud Phenomenon, and Quality of Life in Patients With Systemic Sclerosis: A Pilot Study	7
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study	7
Formulating Knee Osteoarthritis Management Plans Taking Type 2 Diabetes Into Account: Qualitative Study of Arthritis Therapists Using Theoretical Domains Framework	7
Association Between Depressive Symptoms and Self-Reported Physical Activity in Persons With Knee Osteoarthritis	7
Utilization of Rehabilitation Services After Idiopathic Inflammatory Myopathy Diagnosis: A Retrospective Cohort Assessment in the United States	7
MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS: REPORT OF 8 CASES	7
Predictive Value of Severe Symptoms for Residual Disease After Transitioning From High to Low Disease Activity in Axial Spondyloarthritis: A Longitudinal Study	7
Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients With Rheumatoid Arthritis	7
Type I Interferons Promote Development of Flares in Systemic Lupus Erythematosus by Enhancing B-Cell Activation and Differentiation of Age-Associated B Cells	7
Parent Psychological Distress Moderates the Association Between Child Psychopathology and Disease Activity in Children with Juvenile Idiopathic Arthritis	7
Autoantibodies to 14-3-3η: A Novel Diagnostic Biomarker for Axial Spondyloarthritis	7
Ultrasound-Detected Enthesitis Response to Advanced Therapies in Psoriatic Arthritis: A Real-World Study Highlighting Greater Improvement with IL-17 Inhibitors	7
Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody–Associated Dermatomyositis	7
Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe	6
EFFICACY AND SAFETY OF TACROLIMUS IN THE MAINTENANCE TREATMENT OF PATIENTS WITH LUPUS NEPHRITIS	6
A SURVEY OF PATIENTS WITH SLE SUGGESTS LIMITED KNOWLEDGE OF NEPHRITIS UNLESS THERE IS ALREADY CHRONIC KIDNEY DISEASE	6
PROPOSALS FOR DEFINITIONS OF MODERATE AND SEVERE DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. IMPACT ON FLARES, QUALITY OF LIFE, DAMAGE ACCRUAL, HOSPITALIZATIONS AND MORTALITY	6
Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study	6
Imaging in Psoriatic Arthritis: Focus on Axial Magnetic Resonance Imaging and Peripheral Musculoskeletal Ultrasound	6
How Representative Are Data From Clinical Trials in Axial Spondyloarthritis for Women?	6
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	6
Are Patients With Systemic Sclerosis Subject to an Increased Risk of Developing Superficial Erosion of Atherosclerotic Plaques?	6
Infections in Vasculitis: Can We Create an Epidemic of Change?	6
The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease	6
REAL-WORLD EXPERIENCE OF EFFECTIVENESS OF NONMEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB AND BETWEEN BIOSIMILARS IN CONNECTIVE TISSUE DISEASES AND VASCULITIS	6
MPO-ANCA Positivity in a Patient with Pyoderma Gangrenosum and Graves’ Disease: A Case Report and Review of the Literature	6
Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis	6
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response	6
ANIFROLUMAB EFFECTS ON RESPONSE TO INFLUENZA VACCINE IN SLE	6
Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study	6
Tight Control and Radiological Progression: The Radiographic Outcomes of the TICOPA Study	6
Bridging Generations: Leveraging Technology and Artificial Intelligence for Better Research, Outreach, and Daily Practice	6
Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study	6
Patient Perspectives and Experiences With Medication for Gout: A Thematic Synthesis of Qualitative Studies	6
Patient-Provider Communication in Pediatric Rheumatology: A Narrative Review and Presentation of Pilot Data	6
A Frameshift Mutation ofNLRP12in a Patient With Chronic Recurrent Multifocal Osteomyelitis	6
DMARD Utilization Patterns in Community-Dwelling Rheumatoid Arthritis Patients: Insights from Linked Primary Care and Pharmaceutical Data	6
Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by Biological Sex	6
Golimumab for Adherence in Rheumatoid Arthritis (GO FAR): A Multicenter, Prospective, Observational Study of Patients Treated with Golimumab for Rheumatoid Arthritis	6
Janus Kinase Inhibitor Exposure During Pregnancy in Immune-Mediated Inflammatory Diseases: A Case Series of 3 Patients	6
DAPIROLIZUMAB PEGOL DEMONSTRATED IMPROVEMENT IN QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: LUPUSQOL RESULTS FROM A PHASE 3 TRIAL	6
Reflections Across 2 Continents: A Journey Between Canada and the United Arab Emirates	6
TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS	6
In their Own Words: Patient Experiences with Patient Support Programs	6
Arthritis Mutilans in Psoriatic Arthritis: The Consequences of Delayed Treatment	6
The Use of Real-World Data for Studies of Dynamic Disease Processes	6
A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus	6
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	6
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events	6
EFFICACY AND SAFETY OF ELSUBRUTINIB AND UPADACITINIB COMBINATION AND UPADACITINIB MONOTHERAPY FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS THROUGH 104 WEEKS	6
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting	6
Development of National Clinical Practice Guidelines for Transition in Rheumatology	6
The Forgotten Costs of SLE: Estimating Indirect Costs in a National SLE Cohort	6
Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study	6
Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody–Positive Dermatomyositis: An Observational Survey	5
The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis	5
Analyzing Gender Disparities in Ankylosing Spondylitis: Exploring the Factors Behind Severe Sacroiliac Joint Disease Without Spinal Involvement	5
Safety and Healthcare Use Following COVID-19 Vaccination Among Adults With Rheumatoid Arthritis: A Population-Based Self-Controlled Case Series Analysis	5
Ethnic Disparities in Mental Health Screening and Outcomes in Youth with Childhood-Onset Systemic Lupus Erythematosus	5
Bimekizumab Maintained Stringent Clinical Responses Over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies	5
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SLE ACROSS 5 REGISTRIES – THE LUPUSNET FEDERATED DATA NETWORK	5
ANTI-C1Q ANTIBODIES AS INDICATORS OF DISEASE ACTIVITY, RENAL INVOLVEMENT, AND NON-SCARRING ALOPECIA IN PATIENTS WITH SLE	5
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies	5
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region	5
A EULAR/ACR (2019) SLE CLASSIFICATION CRITERIA SCORE ≥20 IS A MARKER OF SEVERE DISEASE IN A PREVALENT SLE COHORT FROM THE PORTUGUESE REUMA.PT REGISTRY	5
PARTNERING WITH ADOLESCENTS AND YOUNG ADULTS WITH CHILDHOOD-ONSET LUPUS TO IMPROVE ENGAGEMENT IN CARE	5
PROTEOMIC ANALYSIS OF SERUM OVER TIME TO FORECAST TREATMENT RESPONSE IN LUPUS NEPHRITIS	5
Immune Checkpoint Inhibitors: A Pediatric Needs Assessment	5
Update to a Systematic Review on Quality Measures for Rheumatoid Arthritis	5
CelebratingThe Journal of Rheumatology’s 50th Year of Publication	5
Autoinflammatory Diseases and Vasculitis: The Missing Link	5
Salivary Inflammatory Biomarkers in Chronic Non-Specific Low Back Pain Patients	5
Dose-Response Relationship Between Alcohol Consumption and Gout Risk: Do Subtypes of Alcoholic Beverages Make a Difference?	5
REDUCED FREQUENCY OF CIRCULATING INTERLEUKIN-16 EXPRESSING CD4+AND CD8+T CELLS ASSOCIATE WITH INCREASED URINARY IL16 LEVELS AND PROMOTE TH1 AND CD8+T CELL MIGRATION IN LUPUS PATIENTS	5
Degenerative Disc Disease in Young Adults With Psoriatic Arthritis	5
Sociocultural and Economic Disparities in Physical Therapy Utilization Among Insured Older Adults With Rheumatoid Arthritis	5
Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample	5
DISTINCT MOLECULAR PROFILES OF REMISSION POST-CD19 CAR-T CELL THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS	5
NONINVASIVE HIGH-THROUGHPUT SERUM PROTEOMICS FOR DISTINGUISHING SUBTYPES OF LUPUS NEPHRITIS	5
50 Years ofThe Journal of Rheumatology	5
DisseminatedMycobacterium haemophilumInfection Mimicking Rheumatoid Nodules	5
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024	5
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	5
Multisystem Sarcoidosis with Extensive Neurologic, Musculoskeletal, Pulmonary, Lymphatic, and Cutaneous Involvement: A Case Report	5
Rapid Review of Transition Outcomes in Youth with Rheumatic Diseases	5
The Road to a New Horizon in Psoriatic Arthritis	5
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group	5
DEVELOPMENT OF A QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) FOR THERAPEUTIC EVALUATION IN A VIRTUAL POPULATION	5
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases	5
Complement Proteins L-Ficolin and M-Ficolin Are Increased in Patients With Axial Spondyloarthritis and Decrease After Tumor Necrosis Factor Inhibitor Treatment	5